New scan may spot dangerous heart blockages without extra probes
NCT ID NCT07176585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether a special ultrasound scan (IVUS) of plaque buildup in heart arteries can accurately diagnose reduced blood flow (functional myocardial ischemia). Researchers enrolled 105 adults with coronary artery disease and compared IVUS results to the standard FFR test. The goal was to see if IVUS plaque measurements could reliably identify blockages that need treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a new, less invasive way to diagnose which heart artery blockages are serious enough to need treatment.
- What could go wrong
- This is a small, single-site study with only 105 participants. The results may not apply to all patients, and the method needs more testing before it can be widely used.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital,Cams & Pumc
Beijing, Beijing Municipality, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan replace invasive heart imaging before bypass surgery?
- Epilepsy drug may protect organs during heart surgery — trial tests the idea
- A simple eye mask might protect sleep and calm confusion after heart surgery
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program